CoNextions received FDA 510(k) clearance to market the Coronet™ tenodesis system for fixation of tissue to bone and tissue to tissue. The product is designed to improve the soft tissue fixation strength of these repairs vs. use of conventional sutures, and its delivery system allows for simultaneous placement of the implant in the bone and soft tissue with a knotless repair.
“This 510(k) furthers our mission at CoNextions while putting quality first, improving the lives of patients by revolutionizing soft tissue repair with safe, innovative, and easy to use medical devices,” said Jeffrey Barnes, CEO. “It is a clear example of our unwavering commitment to creating the most clinically effective and technologically innovative tendon repair solutions. We look forward to Coronet being the first of many exciting products to come.”
CoNextions received FDA 510(k) clearance to market the Coronet™ tenodesis system for fixation of tissue to bone and tissue to tissue. The product is designed to improve the soft tissue fixation strength of these repairs vs. use of conventional sutures, and its delivery system allows for simultaneous placement of the implant in the bone and soft...
CoNextions received FDA 510(k) clearance to market the Coronet™ tenodesis system for fixation of tissue to bone and tissue to tissue. The product is designed to improve the soft tissue fixation strength of these repairs vs. use of conventional sutures, and its delivery system allows for simultaneous placement of the implant in the bone and soft tissue with a knotless repair.
“This 510(k) furthers our mission at CoNextions while putting quality first, improving the lives of patients by revolutionizing soft tissue repair with safe, innovative, and easy to use medical devices,” said Jeffrey Barnes, CEO. “It is a clear example of our unwavering commitment to creating the most clinically effective and technologically innovative tendon repair solutions. We look forward to Coronet being the first of many exciting products to come.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
